share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Nov 23, 2024 05:06

Gainers

  • Exicure (NASDAQ:XCUR) stock rose 41.7% to $15.39 during Friday's pre-market session. The company's market cap stands at $33.4 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) stock rose 34.76% to $0.79. The market value of their outstanding shares is at $6.4 million.
  • Replimune Group (NASDAQ:REPL) stock moved upwards by 23.07% to $13.6. The company's market cap stands at $930.4 million.
  • MSP Recovery (NASDAQ:LIFW) shares increased by 20.27% to $1.78. The company's market cap stands at $2.2 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 12.58% to $3.4. The market value of their outstanding shares is at $2.9 million. As per the press release, Q3 earnings came out today.
  • IO Biotech (NASDAQ:IOBT) stock rose 12.56% to $0.77. The company's market cap stands at $50.5 million.

Losers

  • Autonomix Medical (NASDAQ:AMIX) stock decreased by 55.0% to $6.08 during Friday's pre-market session. The company's market cap stands at $7.0 million.
  • Evotec (NASDAQ:EVO) stock fell 17.01% to $4.44. The company's market cap stands at $1.5 billion.
  • Procaps Gr (NASDAQ:PROC) shares decreased by 14.42% to $0.95. The market value of their outstanding shares is at $107.1 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares decreased by 8.87% to $0.52. The company's market cap stands at $22.2 million.
  • Silexion Therapeutics (NASDAQ:SLXN) shares fell 7.93% to $0.29. The company's market cap stands at $4.2 million.
  • TruBridge (NASDAQ:TBRG) shares declined by 7.88% to $14.75. The market value of their outstanding shares is at $220.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment